A strong quarter for Essilor

Essilor’s revenue rose to CA$159 million in the third quarter of 2014, a 145% increase over the same period last year In North America, sales...

Read More

Valeant increases offer for Allergan

Quebec-based Valeant Pharmaceuticals has increased its takeover bid for Allergan from US$50 to nearly US$60 billion In a letter to Allergan, Valeant...

Read More

Tough quarter for Johnson & Johnson in the eye care market

Despite a good quarter for the company in general (sales of US$185 billion, up by 51% over last year), Johnson & Johnson reported a drop in eye...

Read More

Excellent third quarter for Valeant

Quebec-based Valeant Pharmaceuticals, owner of Bausch + Lomb, among others, recorded its second best quarterly results since it was founded in...

Read More

EyeCheck shortlisted for prestigious James Dyson award

EyeCheck, a start-up founded by University of Waterloo students, made the final list of 20 entries for the James Dyson Award The James Dyson Award...

Read More